Cue Biopharma, Inc. (CUE) vs Voyager Therapeutics, Inc. (VYGR)
- Cue Biopharma, Inc. CUE 16.71 −10.50%
- Voyager Therapeutics, Inc. VYGR 1.90 −7.77%
Cue Biopharma, Inc. and Voyager Therapeutics, Inc. are both Biotechnology companies. Cue Biopharma, Inc. and Voyager Therapeutics, Inc. are of similar size ($135.6M and $126.9M). Cue Biopharma, Inc. grew revenue faster over the last twelve months: 354.4% against −19.1%. Voyager Therapeutics, Inc. has the higher net margin (−312.6% vs −435.8%) and the lower return on invested capital (−192.6% vs 0.00%). Across the 16 metrics below, Cue Biopharma, Inc. leads on 9 and Voyager Therapeutics, Inc. on 7.
Valuation
Profitability
| Metric | CUE | VYGR | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 100.00% | 65.16% |
| Operating margin | (262.03%) | (340.08%) | 0.00% |
| Net margin | (435.83%) | (312.63%) | 0.00% |
| Free cash flow margin | (133.13%) | (352.36%) | 0.00% |
| Return on equity | (1,603.48%) | (54.09%) | (56.36%) |
| Return on assets | (459.60%) | (41.45%) | (48.04%) |
| Return on invested capital | 0.00% | (192.55%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack